Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | chromobox protein, putative | 0.004 | 0.4476 | 0.4776 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0016 | 0.0294 | 0.0058 |
Plasmodium vivax | vivapain-2 | 0.0016 | 0.0242 | 0.5 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0056 | 0.7437 | 0.8116 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0016 | 0.0294 | 0.0323 |
Trypanosoma cruzi | cysteine peptidase, putative | 0.0016 | 0.0242 | 0.0298 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.006 | 0.8123 | 1 |
Trypanosoma cruzi | cysteine peptidase, putative | 0.006 | 0.8123 | 1 |
Schistosoma mansoni | chromobox protein | 0.0066 | 0.9108 | 1 |
Schistosoma mansoni | zinc finger protein | 0.0018 | 0.0717 | 0.0787 |
Toxoplasma gondii | cathepsin CPL | 0.0016 | 0.0242 | 0.5 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0016 | 0.0294 | 0.0323 |
Schistosoma mansoni | cathepsin F (C01 family) | 0.0016 | 0.0242 | 0.0266 |
Brugia malayi | Heterochromatin protein 1 | 0.0066 | 0.9108 | 0.9085 |
Schistosoma mansoni | chromobox protein | 0.0066 | 0.9108 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.2566 | 0.257 |
Schistosoma mansoni | cathepsin F (C01 family) | 0.0016 | 0.0242 | 0.0266 |
Plasmodium falciparum | cysteine proteinase falcipain 2a | 0.0016 | 0.0242 | 0.5 |
Schistosoma mansoni | bromodomain containing protein | 0.006 | 0.8037 | 0.8825 |
Brugia malayi | Bromodomain containing protein | 0.0036 | 0.3853 | 0.37 |
Trypanosoma cruzi | cysteine peptidase, clan CA, family C1, cathepsin L-like, putative | 0.0055 | 0.7196 | 0.8859 |
Plasmodium vivax | vivapain-2 | 0.0016 | 0.0242 | 0.5 |
Echinococcus multilocularis | chromobox protein 1 | 0.0066 | 0.9108 | 1 |
Trichomonas vaginalis | chromobox protein, putative | 0.004 | 0.4476 | 0.4776 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0034 | 0.3456 | 0.3625 |
Leishmania major | cathepsin L-like protease | 0.0016 | 0.0242 | 0.0298 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0894 | 0.0981 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0016 | 0.0294 | 0.0058 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0026 | 0.2069 | 0.2061 |
Entamoeba histolytica | cysteine proteinase, putative | 0.0016 | 0.0242 | 0.5 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.006 | 0.8123 | 1 |
Leishmania major | cathepsin L-like protease | 0.006 | 0.8123 | 1 |
Brugia malayi | PHD-finger family protein | 0.0023 | 0.161 | 0.1402 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.3864 | 0.4006 |
Entamoeba histolytica | cysteine proteinase, putative | 0.0016 | 0.0242 | 0.5 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0037 | 0.3979 | 0.8827 |
Leishmania major | cathepsin L-like protease | 0.0016 | 0.0242 | 0.0298 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0034 | 0.3456 | 0.3625 |
Trichomonas vaginalis | chromobox protein, putative | 0.0066 | 0.9108 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0016 | 0.0294 | 0.0323 |
Leishmania major | cathepsin L-like protease | 0.0016 | 0.0242 | 0.0298 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.006 | 0.8123 | 1 |
Trypanosoma cruzi | cysteine peptidase, putative | 0.006 | 0.8123 | 1 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0056 | 0.7437 | 0.8116 |
Onchocerca volvulus | 0.0029 | 0.2566 | 0.5489 | |
Echinococcus multilocularis | zinc finger protein | 0.0018 | 0.0717 | 0.0535 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.004 | 0.4476 | 1 |
Entamoeba histolytica | cysteine protease, putative | 0.0016 | 0.0242 | 0.5 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0021 | 0.1214 | 0.1096 |
Echinococcus granulosus | methyl CpG binding domain protein 2 | 0.0016 | 0.0294 | 0.0058 |
Trichomonas vaginalis | chromobox protein, putative | 0.0066 | 0.9108 | 1 |
Echinococcus granulosus | chromobox protein 1 | 0.0066 | 0.9108 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.9283 | 1 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0019 | 0.0894 | 0.0721 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.3979 | 0.4133 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.4261 | 0.4445 |
Leishmania major | cathepsin L-like protease | 0.006 | 0.8123 | 1 |
Trypanosoma cruzi | cysteine peptidase, putative | 0.006 | 0.8123 | 1 |
Echinococcus multilocularis | chromobox protein 1 | 0.0066 | 0.9108 | 1 |
Brugia malayi | chromobox protein homolog 3 | 0.0037 | 0.3979 | 0.383 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.4581 | 0.4799 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0294 | 0.0057 |
Leishmania major | cathepsin L-like protease | 0.0016 | 0.0242 | 0.0298 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0017 | 0.0397 | 0.0171 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.006 | 0.8123 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0037 | 0.3979 | 0.4215 |
Trypanosoma cruzi | cruzipain precursor, putative | 0.006 | 0.8123 | 1 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.006 | 0.8123 | 1 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.006 | 0.8123 | 1 |
Trypanosoma cruzi | major cysteine proteinase, putative | 0.0047 | 0.5836 | 0.7185 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0021 | 0.1214 | 0.1096 |
Leishmania major | cathepsin L-like protease | 0.006 | 0.8123 | 1 |
Leishmania major | cathepsin L-like protease | 0.0016 | 0.0242 | 0.0298 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0016 | 0.0294 | 0.0323 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0021 | 0.1214 | 0.1332 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.006 | 0.8123 | 1 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.006 | 0.8123 | 1 |
Plasmodium falciparum | cysteine proteinase falcipain 2b | 0.0016 | 0.0242 | 0.5 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.006 | 0.8123 | 1 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.006 | 0.8123 | 1 |
Loa Loa (eye worm) | heterochromatin protein 1 | 0.0066 | 0.9108 | 0.9805 |
Plasmodium falciparum | cysteine proteinase falcipain 3 | 0.0016 | 0.0242 | 0.5 |
Echinococcus granulosus | zinc finger protein | 0.0018 | 0.0717 | 0.0535 |
Echinococcus granulosus | chromobox protein 1 | 0.0066 | 0.9108 | 1 |
Echinococcus multilocularis | methyl CpG binding domain protein 2 | 0.0016 | 0.0294 | 0.0058 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0037 | 0.3979 | 0.4215 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0026 | 0.2069 | 0.2061 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.006 | 0.8123 | 1 |
Leishmania major | cysteine peptidase A (CPA) | 0.0016 | 0.0242 | 0.0298 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 106 % | Growth inhibition of Cloudman S91 Melanoma cells at 10 microM drug concentration. | ChEMBL. | 7120285 |
Inhibition (functional) | = 106 % | Growth inhibition of Cloudman S91 Melanoma cells at 10 microM drug concentration. | ChEMBL. | 7120285 |
Inhibition (functional) | = 134 % | Growth inhibition of Cloudman S91 Melanoma cells at 1 microM drug concentration. | ChEMBL. | 7120285 |
Inhibition (functional) | = 134 % | Growth inhibition of Cloudman S91 Melanoma cells at 1 microM drug concentration. | ChEMBL. | 7120285 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.